RGFP966
CAS: 1396841-57-8
Ref. 3D-WFC84157
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued | ||
100mg | Discontinued |
Product Information
RGFP966 is a pharmacological agent that belongs to the class of HDAC inhibitors. It has been shown to attenuate cardiac hypertrophy in experimental models by regulating iron homeostasis and angiotensin system signaling. RGFP966 also inhibits cellular proliferation by inducing apoptosis via the mitochondrial pathway. This drug also has anti-inflammatory effects, reducing the expression of chemoattractant protein, which can be beneficial for treating metabolic disorders such as myocardial infarcts and diabetes.